Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum VALEANT PHARMACEUTICALS INTL INC T.VRX

"Valeant Pharmaceuticals is a global specialty pharmaceutical firm with a focus on branded products for the dermatology, gastrointestinal, and ophthalmology markets. The firm also has a branded generics business that operates primarily in Latin America, Eastern Europe, and Asia."

TSX:VRX - Post Discussion

VALEANT PHARMACEUTICALS INTL INC > VRX expect $60 a share
View:
Post by PanWest on Mar 03, 2017 12:02pm

VRX expect $60 a share

My entry $17.60
i have gone and it will happen
Comment by PanWest on Mar 03, 2017 12:07pm
Valeant Pharma (NYSE: VRX) reported Q4 EPS of $1.26, $0.05 better than the analyst estimate of $1.21. Revenue for the quarter came in at $2.4 billion versus the consensus estimate of $2.34 billion. Read more at https://www.stockhouse.com/companies/bullboard?symbol=t.vrx&postid=25909760#fF89JqAryOMciiQf.99
Comment by yrmac on Mar 03, 2017 12:07pm
You will be very old when the $60.00 will happen have a nice day
Comment by Joe454 on Mar 03, 2017 12:12pm
This post has been removed in accordance with Community Policy
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities